HUE036585T2 - Sokgénes prognosztizáló ASSAY tüdõrákra - Google Patents

Sokgénes prognosztizáló ASSAY tüdõrákra

Info

Publication number
HUE036585T2
HUE036585T2 HUE12807429A HUE12807429A HUE036585T2 HU E036585 T2 HUE036585 T2 HU E036585T2 HU E12807429 A HUE12807429 A HU E12807429A HU E12807429 A HUE12807429 A HU E12807429A HU E036585 T2 HUE036585 T2 HU E036585T2
Authority
HU
Hungary
Prior art keywords
lung cancer
prognostic assay
multigene
multigene prognostic
assay
Prior art date
Application number
HUE12807429A
Other languages
English (en)
Inventor
Michael Mann
David Jablons
Johannes Kratz
David Berryman
Original Assignee
Univ California
Encore Clinical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California, Encore Clinical Inc filed Critical Univ California
Publication of HUE036585T2 publication Critical patent/HUE036585T2/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407Specifically defined cancers
    • G01N33/57423Specifically defined cancers of lung
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/118Prognosis of disease development
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/52Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Hospice & Palliative Care (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • General Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
HUE12807429A 2011-07-01 2012-06-29 Sokgénes prognosztizáló ASSAY tüdõrákra HUE036585T2 (hu)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161504063P 2011-07-01 2011-07-01
US201161504193P 2011-07-02 2011-07-02

Publications (1)

Publication Number Publication Date
HUE036585T2 true HUE036585T2 (hu) 2018-07-30

Family

ID=47437384

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE12807429A HUE036585T2 (hu) 2011-07-01 2012-06-29 Sokgénes prognosztizáló ASSAY tüdõrákra

Country Status (9)

Country Link
US (1) US9476098B2 (hu)
EP (1) EP2726635B1 (hu)
CN (1) CN103998622A (hu)
AU (1) AU2012279173B2 (hu)
DK (1) DK2726635T3 (hu)
ES (1) ES2658921T3 (hu)
HU (1) HUE036585T2 (hu)
PL (1) PL2726635T3 (hu)
WO (1) WO2013006503A1 (hu)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140147855A1 (en) * 2011-07-01 2014-05-29 Pinpoint Genomics, Inc. Method for Extracting RNA from Fixed Embedded Tissue
PL2726635T3 (pl) 2011-07-01 2018-04-30 The Regents Of The University Of California Multigenowy prognostyczny test na raka płuc
WO2014149629A1 (en) * 2013-03-15 2014-09-25 Htg Molecular Diagnostics, Inc. Subtyping lung cancers
US9526611B2 (en) 2013-10-29 2016-12-27 Tendyne Holdings, Inc. Apparatus and methods for delivery of transcatheter prosthetic valves
CN105985422A (zh) * 2015-01-30 2016-10-05 天津奥维亚生物技术有限公司 一种人sh3bgr多肽及其抗体制备方法
EP3283010B1 (en) 2015-04-16 2020-06-17 Tendyne Holdings, Inc. Apparatus for delivery and repositioning of transcatheter prosthetic valves
CN105954517B (zh) * 2016-06-30 2018-09-18 四川大学华西医院 一种肺癌筛查试剂盒
CN105929164B (zh) * 2016-06-30 2018-06-26 四川大学华西医院 一种肺癌筛查试剂盒
CN106119405B (zh) * 2016-08-31 2019-11-12 广州万德基因医学科技有限公司 一种肺癌的预后标记物、使用该标记预测肺癌预后的方法及应用
CN113811767A (zh) * 2018-12-21 2021-12-17 百奥马克癌症系统公司 检测肺癌的方法
CN109859801B (zh) * 2019-02-14 2023-09-19 辽宁省肿瘤医院 一种含有七个基因作为生物标志物预测肺鳞癌预后的模型及建立方法
EP3831343B1 (en) 2019-12-05 2024-01-31 Tendyne Holdings, Inc. Braided anchor for mitral valve
US11648114B2 (en) 2019-12-20 2023-05-16 Tendyne Holdings, Inc. Distally loaded sheath and loading funnel
US11951002B2 (en) 2020-03-30 2024-04-09 Tendyne Holdings, Inc. Apparatus and methods for valve and tether fixation
CN111564177B (zh) * 2020-05-22 2023-03-31 四川大学华西医院 基于dna甲基化的早期非小细胞肺癌复发模型构建方法
CN112037863B (zh) * 2020-08-26 2022-06-21 南京医科大学 一种早期nsclc预后预测系统
CN114438188A (zh) * 2021-11-29 2022-05-06 中国辐射防护研究院 高甲基化CDK2AP1基因作为α辐射损伤预测的分子标志物的用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5885527A (en) 1992-05-21 1999-03-23 Biosite Diagnostics, Inc. Diagnostic devices and apparatus for the controlled movement of reagents without membrances
US7955800B2 (en) * 2002-06-25 2011-06-07 Advpharma Inc. Metastasis-associated gene profiling for identification of tumor tissue, subtyping, and prediction of prognosis of patients
US20100240035A1 (en) 2007-06-01 2010-09-23 The Regents Of The University Of California Multigene prognostic assay for lung cancer
AU2011223789A1 (en) 2010-03-01 2012-09-20 Caris Life Sciences Switzerland Holdings Gmbh Biomarkers for theranostics
PL2726635T3 (pl) 2011-07-01 2018-04-30 The Regents Of The University Of California Multigenowy prognostyczny test na raka płuc

Also Published As

Publication number Publication date
EP2726635A4 (en) 2015-02-18
EP2726635B1 (en) 2017-11-08
AU2012279173A1 (en) 2013-05-09
PL2726635T3 (pl) 2018-04-30
CN103998622A (zh) 2014-08-20
AU2012279173B2 (en) 2016-06-16
WO2013006503A1 (en) 2013-01-10
DK2726635T3 (en) 2018-02-12
EP2726635A1 (en) 2014-05-07
ES2658921T3 (es) 2018-03-12
US9476098B2 (en) 2016-10-25
US20130059747A1 (en) 2013-03-07

Similar Documents

Publication Publication Date Title
HUE036585T2 (hu) Sokgénes prognosztizáló ASSAY tüdõrákra
HK1193637A1 (en) Biomarkers for lung cancer
IL252163A0 (en) Lung cancer biomarkers and their uses
EP2534265A4 (en) SALIVARY BIOMARKERS FOR THE DETECTION OF LUNG CANCER
EP2718721A4 (en) CIRCULATING BIOMARKERS FOR CANCER
EP2585833A4 (en) METHODS OF DETECTING CANCER
EP2698634A4 (en) BIOMARKER FOR BREAST CANCER
EP2828405A4 (en) MARKER PANEL FOR DETECTING CANCER
EP2668295A4 (en) METHODS OF DETECTING LUNG CANCER
EP2748608A4 (en) LUNG CANCER TESTS
SG11201602019XA (en) Multigene assay for prognosis of renal cancer
IL227419A0 (en) Symptomatic signature for colon cancer recurrence
EP2877855A4 (en) MULTISIGNAL REAGENTS FOR MARKING ANALYTES
EP2691545A4 (en) METHOD FOR CLASSIFYING LUNG CANCER
GB201003485D0 (en) Kidney prognostic assay
EP2758777A4 (en) PROOF OF EGG CANCER
GB2494580B (en) Method for diagnosing lung cancer
EP2753716A4 (en) NEW RISK BIO MARKERS FOR LUNG CANCER
GB2510539B (en) Biomarkers of cancer
HK1175534A1 (zh) 具有增强的測量性能的生物傳感器除濕劑系統
WO2012167112A9 (en) Gastric cancer biomarkers
GB201113968D0 (en) Prognostic methadology
GB201104556D0 (en) Biomarkers
WO2012103424A9 (en) Diagnostic and prognostic markers for metastasis
EP2521797A4 (en) DNA METHYLATION BIOMARKER FOR LUNG FUNCTION